EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dasatinib and Quercetin Combination Increased Kidney Damage in Acute Folic Acid-Induced Experimental Nephropathy

Antonio Battaglia-Vieni iD, Vanessa Marchant iD, Lucia Tejedor-Santamaria iD, Cristina García-Caballero, Elena Flores-Salguero iD, María Piedad Ruiz-Torres, Sandra Rayego-Mateos iD, Ana Belen Sanz, Alberto Ortiz iD, Marta Ruiz-Ortega iD

Pharmaceuticals · 30.05.2025 · 18 (6) · 822

DOI: 10.3390/ph18060822 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 30.05.2025. Verfasst von Antonio Battaglia-Vieni und 9 weiteren Autor:innen. Beteiligte Einrichtung: Molecular and Cellular Biology in Renal and Vascular Pathology Laboratory, Department of Medicine, IIS-Fundación Jiménez Díaz, Universidad Autónoma d…. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III (ISCIII) and Fondos FEDER European Union, Comunidad de Madrid, Instituto de Salud Carlos III (ISCIII).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Acute kidney injury (AKI) remains an unsolved medical problem due to the lack of effective treatments, high mortality, and increased susceptibility to progression to chronic kidney disease (CKD), especially in the elderly. Cellular senescence has been described in AKI, CKD, and aging and has been proposed as a promising therapeutic target. The senolytic drug combination of dasatinib plus quercetin (D&Q) is beneficial in some pathological conditions, including experimental CKD, but there are no data for AKI.

Methods

The effect of D&Q combination was tested in folic acid-induced nephrotoxicity (FAN-AKI), a murine AKI model.

Results

D&Q pretreatment did not prevent renal dysfunction in the acute phase of FAN-AKI, as determined by serum creatinine and BUN levels at 48 h. Moreover, gene expression of the kidney damage biomarkers Lcn2 and Havcr1, the Cdkn1a gene, which encodes p21, and some genes encoding components of the senescent cell secretome were significantly increased in response to D&Q treatment. The number of senescent p21-positive cells in injured kidneys was similar in untreated or D&Q-treated FAN mice. In addition, D&Q did not prevent the downregulation of the antiaging factor Klotho in damaged kidneys.

Conclusions

D&Q treatment was not protective in FAN-AKI, exacerbating some deleterious responses. These results suggest caution when exploring the clinical translation of D&Q senolytic activity.

Schlagwörter

Stichwörter der Autor:innen

Klothoacute kidney injurydasatinibp21quercetinsenescencesenolytics

Autor:innen und Institutionen

  • Molecular and Cellular Biology in Renal and Vascular Pathology Laboratory, Department of Medicine, IIS-Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Avda. Reyes Católicos, 2, 28040 Madrid, Spain.
  • Ricors2040, Instituto de Salud Carlos III, 28029 Madrid, Spain.
  • Inflammation and Immunopathology of Organs and Systems Laboratory, University Hospital La Princesa, C/Diego de León 62, 28006 Madrid, Spain.
  • Department of Systems Biology, University of Alcalá, 28871 Alcalá de Henares, Spain.
  • Division of Nephrology and Hypertension, IIS-Fundación Jiménez Díaz, Universidad Autónoma Madrid, 28040 Madrid, Spain.

ORCID-Profile: Antonio Battaglia-Vieni, Vanessa Marchant, Lucia Tejedor-Santamaria, Elena Flores-Salguero, Sandra Rayego-Mateos, Alberto Ortiz, Marta Ruiz-Ortega

Förderung

  • Instituto de Salud Carlos III (ISCIII) and Fondos FEDER European Union
  • Comunidad de Madrid
  • Instituto de Salud Carlos III (ISCIII)
  • European Union
  • INNOREN

Zitieren

APA

Battaglia-Vieni, A., Marchant, V., Tejedor-Santamaria, L., García-Caballero, C., Flores-Salguero, E., Ruiz-Torres, M. P., Rayego-Mateos, S., Sanz, A. B., Ortiz, A., & Ruiz-Ortega, M. (2025). Dasatinib and Quercetin Combination Increased Kidney Damage in Acute Folic Acid-Induced Experimental Nephropathy. Pharmaceuticals, 18(6), 822. https://doi.org/10.3390/ph18060822

Vancouver

Battaglia-Vieni A, Marchant V, Tejedor-Santamaria L, García-Caballero C, Flores-Salguero E, Ruiz-Torres MP, et al. Dasatinib and Quercetin Combination Increased Kidney Damage in Acute Folic Acid-Induced Experimental Nephropathy. Pharmaceuticals. 2025;18(6):822. doi:10.3390/ph18060822

BibTeX
@article{BattagliaVieni2025,
  author = {Battaglia-Vieni, Antonio and Marchant, Vanessa and Tejedor-Santamaria, Lucia and García-Caballero, Cristina and Flores-Salguero, Elena and Ruiz-Torres, María Piedad and Rayego-Mateos, Sandra and Sanz, Ana Belen and Ortiz, Alberto and Ruiz-Ortega, Marta},
  title = {Dasatinib and Quercetin Combination Increased Kidney Damage in Acute Folic Acid-Induced Experimental Nephropathy},
  journal = {Pharmaceuticals},
  year = {2025},
  volume = {18},
  number = {6},
  pages = {822},
  doi = {10.3390/ph18060822}
}
Kostenlos starten →